SCHEMBL28391913

SCHEMBL28391913

N#Cc1c(C2CCc3ccc(F)cc3C2)n[nH]c1N

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 1/20 0.36
▸ ADORA1 P30542 1/20 0.36
▸ GAA P10253 1/20 0.34
▸ GFER P55789 1/20 0.34
▸ PIK3CD O00329 1/20 0.34
▸ PIK3CA P42336 1/20 0.34
▸ PIK3CB P42338 1/20 0.34
▸ PIK3CG P48736 1/20 0.34
▸ PRKDC P78527 1/20 0.34
▸ HTR1D P28221 1/20 0.33
▸ HTR1B P28222 1/20 0.33
▸ HCAR2 Q8TDS4 3/20 0.32
▸ SLC6A4 P31645 2/20 0.32
▸ ADRA2A P08913 1/20 0.32
▸ ADRA2B P18089 1/20 0.32
▸ ADRA2C P18825 1/20 0.32
▸ HTR5A P47898 2/20 0.32
▸ PRKACA P17612 1/20 0.32
▸ PRKACG P22612 1/20 0.32
▸ PRKACB P22694 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17447903 0.96 ADORA2A (0.36) ADORA2AADORA1GAAGFERPIK3CD
SCHEMBL17447896 0.85 PIK3CD (0.45) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL17447898 0.85 PIK3CD (0.45) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL17448011 0.82 ALK (0.40) ADORA2AADORA1GAAGFERPIK3CG
SCHEMBL28400077 0.74 CTSD (0.35) GAAPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL17447964 0.74 CTSD (0.35) GAAPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL31278318 0.72 PRKACA (0.46) ADORA2AADORA1GAAGFERPRKACA
SCHEMBL17448043 0.70 NISCH (0.35) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL17447930 0.67 NISCH (0.44) PRKACAPRKACGPRKACB
SCHEMBL21877758 0.65 PRKACA (0.38) GAAGFERPRKACAPRKACGPRKACB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106687446-B 5-amino-4-carbamoyl-pyrazole compounds as selective and irreversible kinase inhibitors of T790M/WT-EGFR and uses thereof 百济神州(北京)生物科技有限公司 2020-04-28 — — CN disclosed
Send feedback